BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 (compounding only, no legal prescribing) into Category 1. This means When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Evaluates Peptides for Section 503A Compounding List Lance Liberti, MBA, BCPA posted on the topic LinkedIn FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies FDA Peptide Update: Category 2 Removals Explained